Comparison of Side Effects and Tolerability Between Intravesical Bacillus Calmette-Guerin, Reduced-Dose BCG and Gemcitabine for Non-Muscle Invasive Bladder Cancer

To compare patient-reported side effects and tolerability of full-dose Bacillus Calmette-Guérin (BCG), reduced-dose BCG, and gemcitabine one week after administration. All patients from July 2019 to November 2020 receiving intravesical therapy (IVT) for non-muscle invasive bladder cancer (NMIBC) at...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Urology (Ridgewood, N.J.) N.J.), 2021-10, Vol.156, p.191-198
Hauptverfasser:	Kuperus, Joshua M., Busman, Ross D., Kuipers, Susan K., Broekhuizen, Helen T., Noyes, Sabrina L., Brede, Christopher M., Tobert, Conrad M., Lane, Brian R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants, Immunologic - administration & dosage Adjuvants, Immunologic - adverse effects Administration, Intravesical Aged Antimetabolites, Antineoplastic - administration & dosage Antimetabolites, Antineoplastic - adverse effects BCG Vaccine - administration & dosage BCG Vaccine - adverse effects Deoxycytidine - administration & dosage Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Dose-Response Relationship, Drug Drug Monitoring - methods Drug Monitoring - statistics & numerical data Drug Tapering - methods Drug-Related Side Effects and Adverse Reactions - classification Drug-Related Side Effects and Adverse Reactions - diagnosis Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - etiology Female Humans Male Neoplasm Invasiveness Neoplasm Staging Patient Reported Outcome Measures Prevalence Symptom Assessment - methods Symptom Assessment - statistics & numerical data Urinary Bladder Neoplasms - drug therapy Urinary Bladder Neoplasms - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!